SEC Form 4 · accession 0001445064-15-000144
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hugh M. O'Neill
Officer — SVP & Pres, ARD
Period of report
Nov 27, 2015
Accepted (ET)
Dec 1, 2015 · 9:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Nov 27, 2015 | P | 750 | $66.78 | A | 9,765 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $66.655 to $66.80, inclusive. Mr. O'Neill will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.